Fibrinolytic activity in men with acute myocardial infarction before 60 years of age

Related Experiment Videos

Acta Medica Scandinavica
|January 1, 1983
PubMed

Insights

Men who had a myocardial infarction before age 60 showed reduced plasma fibrinolytic activity, especially those with high diastolic blood pressure. This suggests impaired blood clot breakdown post-heart attack, linked to apolipoprotein AI levels.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Biochemistry

Background:

  • Acute myocardial infarction (AMI) survivors may experience long-term cardiovascular complications.
  • Fibrinolytic activity is crucial for dissolving blood clots and maintaining vascular health.
  • Impaired fibrinolysis is implicated in thrombotic events and cardiovascular disease progression.

Purpose of the Study:

  • To investigate plasma fibrinolytic activity in men following an early-life myocardial infarction.
  • To compare fibrinolytic capacity between AMI survivors with normal and elevated diastolic blood pressure and healthy controls.
  • To explore potential correlations between fibrinolysis and specific biomarkers like apolipoprotein AI.

Main Methods:

  • Assessed plasma fibrinolytic activity using venous occlusion in 66 men 1-5 years post-MI (before age 60) and 32 age/sex-matched controls.
  • Subdivided MI group based on diastolic blood pressure (normal vs. elevated).
  • Employed variance analysis and Student's t-test for statistical comparisons; analyzed relationship with apolipoprotein AI.

Main Results:

  • No statistically significant differences in fibrinolytic activity were found between the three groups via variance analysis.
  • However, Student's t-test revealed significantly lower fibrinolytic activity in the MI group with elevated diastolic pressure compared to the reference group.
  • A significant relationship was identified between apolipoprotein AI levels and fibrinolytic activity after repeated provocation.

Conclusions:

  • Men with a history of early myocardial infarction, particularly those with elevated diastolic blood pressure, may exhibit reduced fibrinolytic capacity.
  • Impaired fibrinolysis post-MI could contribute to an increased risk of recurrent thrombotic events.
  • Apolipoprotein AI may play a role in modulating fibrinolytic function in this patient population.

Related Concept Videos